Risultati della ricerca - Peter van Sluis
- Mostra 1 - 20 risultati su 28
- Vai alla pagina seguente
-
1
-
2
A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma di Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Köster, Rogier Versteeg
Pubblicazione 2013Artigo -
3
-
4
Functional MYCN signature predicts outcome of neuroblastoma irrespective of <i>MYCN</i> amplification di Linda J. Valentijn, Jan Köster, Franciska Haneveld, Rachida Ait Aissa, Peter van Sluis, Marloes E.C. Broekmans, Jan J. Molenaar, Johan van Nes, Rogier Versteeg
Pubblicazione 2012Artigo -
5
Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with Neuroblastoma di Huib N. Caron, Peter van Sluis, Jan de Kraker, Jos P.M. Bökkerink, Maarten Egeler, Geneviève Laureys, Rosalyn Slater, A. Westerveld, P.A. Voûte, Rogier Versteeg
Pubblicazione 1996Artigo -
6
Copy number defects of G1‐Cell cycle genes in neuroblastoma are frequent and correlate with high expression of <i>E2F</i> target genes and a poor prognosis di Jan J. Molenaar, Jan Köster, Marli E. Ebus, Peter van Sluis, Ellen M. Westerhout, Katleen De Preter, David Gisselsson, Ingrid Øra, Frank Speleman, Huib N. Caron, Rogier Versteeg
Pubblicazione 2011Artigo -
7
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis di Kathy Boon, Huib N. Caron, Ronald van Asperen, Linda J. Valentijn, Marie-Christine Hermus, Peter van Sluis, Ilja Roobeek, Isabel Weis, P.A. Voûte, Manfred Schwab, Rogier Versteeg
Pubblicazione 2001Artigo -
8
RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma di Thomas F. Eleveld, Linda Schild, Jan Köster, Danny A. Zwijnenburg, Lindy K. Alles, Marli E. Ebus, Richard Volckmann, Godelieve A. Tijtgat, Peter van Sluis, Rogier Versteeg, Jan J. Molenaar
Pubblicazione 2018Artigo -
9
OTX1 and OTX2 Expression Correlates With the Clinicopathologic Classification of Medulloblastomas di Talitha de Haas, Esmeralda Oussoren, Wiesława Grajkowska, Marta Perek‐Polnik, Mara Popović, Lorna Zadravec Zaletel, Marzia Perera, Giorgio Corte, Oliver Wirths, Peter van Sluis, Torsten Pietsch, Dirk Troost, Frank Baas, Rogier Versteeg, Marcel Kool
Pubblicazione 2006Artigo -
10
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma di E E Santo, M E Ebus, Jan Köster, Johannes H. Schulte, Arjan Lakeman, Peter van Sluis, Joëlle Vermeulen, David Gisselsson, Ingrid Øra, Scott Lindner, P G Buckley, R. L. Stallings, Jo Vandesompele, Angelika Eggert, HN Caron, Rogier Versteeg, J Jaap Molenaar
Pubblicazione 2011Artigo -
11
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features di Marcel Kool, Jan Köster, Jens Bunt, Nancy E. Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten-van Meeteren, Huib N. Caron, Jacqueline Cloos, Alan Mršić, Bauke Ylstra, Wiesława Grajkowska, Wolfgang Hartmann, Torsten Pietsch, David W. Ellison, Steven C. Clifford, Rogier Versteeg
Pubblicazione 2008Artigo -
12
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma di Tim van Groningen, Nurdan Akogul, Ellen M. Westerhout, Alvin Chan, Nancy E. Hasselt, Danny A. Zwijnenburg, Marloes E.C. Broekmans, Peter Stroeken, Franciska Haneveld, Gerrit K. Hooijer, C. Dilara Savci‐Heijink, Arjan Lakeman, Richard Volckmann, Peter van Sluis, Linda J. Valentijn, Jan Köster, Rogier Versteeg, Johan van Nes
Pubblicazione 2019Artigo -
13
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs di Sudipto Das, Kenneth Bryan, P G Buckley, Olga Piskareva, I M Bray, Niamh H. Foley, Joseph P. Ryan, Joseph P. Lynch, Laura Creevey, Joanna Fay, Suzanne Prenter, Jan Köster, Peter van Sluis, Rogier Versteeg, Angelika Eggert, Johannes H. Schulte, Alexander Schramm, Pieter Mestdagh, Jo Vandesompele, Frank Speleman, R. L. Stallings
Pubblicazione 2012Artigo -
14
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR) di Andrey Korshunov, Marina Ryzhova, David Jones, Paul A. Northcott, Peter van Sluis, Richard Volckmann, Jan Köster, Rogier Versteeg, Cynthia Cowdrey, Arie Perry, Daniel Picard, Marc K. Rosenblum, Felice Giangaspero, Eleonora Aronica, Ulrich Schüller, Martin Hasselblatt, V. Peter Collins, Andreas von Deimling, Peter Lichter, Annie Huang, Stefan M. Pfister, Marcel Kool
Pubblicazione 2012Artigo -
15
Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors di Ellen M. Westerhout, Mohamed Hamdi, Peter Stroeken, Natalia E. Nowakowska, Arjan Lakeman, Jennemiek van Arkel, Nancy E. Hasselt, Boris Bleijlevens, Nurdan Akogul, Franciska Haneveld, Alvin Chan, Peter van Sluis, Danny A. Zwijnenburg, Richard Volckmann, Carel J.M. van Noesel, Igor Adameyko, Tim van Groningen, Jan Köster, Linda J. Valentijn, Johan van Nes, Rogier Versteeg
Pubblicazione 2021Artigo -
16
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes di Jan J. Molenaar, Jan Köster, Danny A. Zwijnenburg, Peter van Sluis, Linda J. Valentijn, Ida van der Ploeg, Mohamed Hamdi, Johan van Nes, Bart A. Westerman, Jennemiek van Arkel, Marli E. Ebus, Franciska Haneveld, Arjan Lakeman, Linda Schild, Piet Molenaar, Peter Stroeken, Max M. van Noesel, Ingrid Øra, Evan E. Santo, Huib N. Caron, Ellen M. Westerhout, Rogier Versteeg
Pubblicazione 2012Artigo -
17
miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples di Katleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, Fjoralba Zeka, Arlene Naranjo, Isabella Bray, Victoria Castel, Caifu Chen, Elżbieta Drożyńska, Angelika Eggert, Michael D. Hogarty, Ewa Iżycka‐Świeszewska, Wendy B. London, Rosa Noguera, Marta Piqueras, Kenneth Bryan, Benjamin Schowe, Peter van Sluis, Jan J. Molenaar, Alexander Schramm, Johannes H. Schulte, Raymond L. Stallings, Rogier Versteeg, Geneviève Laureys, Nadine Van Roy, Frank Speleman, Jo Vandesompele
Pubblicazione 2011Artigo -
18
Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors di Jenny Wegert, Naveed Ishaque, Romina Vardapour, Christina Geörg, Zuguang Gu, Matthias Bieg, Barbara Ziegler, Sabrina Bausenwein, Nasenien Nourkami, Nicole Ludwig, Andreas Keller, Clemens Grimm, Susanne Kneitz, Richard D. Williams, Tas Chagtai, Kathy Pritchard‐Jones, Peter van Sluis, Richard Volckmann, Jan Köster, Rogier Versteeg, Tomás Acha, Maureen J. O’Sullivan, Peter Bode, Felix Niggli, Godelieve A.M. Tytgat, Harm van Tinteren, Marry M. van den Heuvel‐Eibrink, Eckart Meese, Christian Vokuhl, Ivo Leuschner, Norbert Graf, Roland Eils, Stefan M. Pfister, Marcel Kool, Manfred Gessler
Pubblicazione 2015Artigo -
19
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients di Marc van de Wetering, Hayley E. Francies, Joshua M. Francis, Gergana Bounova, Francesco Iorio, Apollo Pronk, Winan J. van Houdt, Joost van Gorp, Amaro Taylor‐Weiner, Lennart Kester, Anne McLaren-Douglas, Joyce Blokker, Sridevi Jaksani, Sina Bartfeld, Richard Volckman, Peter van Sluis, Vivian Li, Sara Seepo, Chandra Sekhar Pedamallu, Kristian Cibulskis, Scott L. Carter, Aaron McKenna, Michael S. Lawrence, Lee Lichtenstein, Chip Stewart, Jan Köster, Rogier Versteeg, Alexander van Oudenaarden, Julio Sáez-Rodríguez, Robert G.J. Vries, Gad Getz, Lodewyk F.A. Wessels, Michael R. Stratton, Ultan McDermott, Matthew Meyerson, Mathew J. Garnett, Hans Clevers
Pubblicazione 2015Artigo -
20
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations di Thomas F. Eleveld, Derek A. Oldridge, Virginie Bernard, Jan Köster, Léo Colmet‐Daage, Sharon J. Diskin, Linda Schild, Nadia Bessoltane Bentahar, Angela Bellini, Mathieu Chicard, Eve Lapouble, Valérie Combaret, Patricia Legoix-Né, Jean Michon, Trevor J. Pugh, Lori S. Hart, JulieAnn Rader, Edward F. Attiyeh, Jun S. Wei, Shile Zhang, Arlene Naranjo, Julie M. Gastier‐Foster, Michael D. Hogarty, Shahab Asgharzadeh, Malcolm A. Smith, Jaime M. Guidry Auvil, Thomas B.K. Watkins, Danny A. Zwijnenburg, Marli E. Ebus, Peter van Sluis, Anne Hakkert, Esther van Wezel, C. Ellen van der Schoot, Ellen M. Westerhout, Johannes H. Schulte, Godelieve A.M. Tytgat, M. Emmy M. Dolman, Isabelle Janoueix‐Lerosey, Daniela S. Gerhard, Huib N. Caron, Olivier Delattre, Javed Khan, Rogier Versteeg, Gudrun Schleiermacher, Jan J. Molenaar, John M. Maris
Pubblicazione 2015Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Genetics
Gene
Cancer research
Cell culture
Neuroblastoma
Medicine
Gene expression
Cancer
Mutation
Pathology
Medulloblastoma
Cell biology
Signal transduction
microRNA
Cell cycle
Computational biology
Epigenetics
Transcription factor
Carcinogenesis
DNA methylation
Enhancer
Gene silencing
Immunohistochemistry
Internal medicine
MAPK/ERK pathway
Mesenchymal stem cell
PTCH1
Phenotype
RNA